An‐Cheng Shiau

Cytosolic high-mobility group box protein 1 (HMGB1) and/or PD-1+ TILs in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapy

Kevin Chih‐Yang Huang, Shu‐Fen Chiang, Tao‐Wei Ke et al. · Cancer Immunology Immunotherapy · 2017 · 69 citations · Full text

Medicine, Molecular Biology, Oncology +17

Radiation injury to intestine following hysterectomy and adjuvant radiotherapy for cervical cancer

Shang-Wen Chen, Ji‐An Liang, Shih-Neng Yang et al. · Gynecologic Oncology · 2004 · 53 citations

Medicine, Oncology, Radiation Oncology +16

Engineered sTRAIL-armed MSCs overcome STING deficiency to enhance the therapeutic efficacy of radiotherapy for immune checkpoint blockade

Kevin Chih‐Yang Huang, Shu‐Fen Chiang, Hsin-Yu Chang et al. · Cell Death and Disease · 2022 · 47 citations · Full text

Medicine, Immunology, Oncology +17

Comparative dosimetric study of two strategies of intensity-modulated radiotherapy in nasopharyngeal cancer

Shang-Wen Chen, Shih-Neng Yang, Ji‐An Liang et al. · Medical dosimetry · 2005 · 42 citations

Medicine, Oncology, Radiation Oncology +16

Value of Computed Tomography‐Based Tumor Volume as a Predictor of Outcomes in Hypopharyngeal Cancer After Treatment With Definitive Radiotherapy

Shang‐Wen Chen, Shih‐Neng Yang, Ji‐An Liang et al. · The Laryngoscope · 2006 · 36 citations

Medicine, Oncology, Radiation Oncology +15